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Background
Patients with ACS who needs CABG are surgical challenge
due to their instability, potential unrecognized co-morbid-
ity, and the need for urgent treatment. Dual antiplatelet
therapy (clopidogrel + aspirin) has to be given to almost
all patients before coronarography. The same therapy
becomes a threat to cardiac surgeons as it may have
deleterious effects on surgical haemostasis.
Methods
At our Institute, 122 patients with ACS were surgically
revascularized using extracorporeal circulation in the first
10 days after the coronarography by one surgical team in
the 5 years period. Patients were stratified into two
groups: 65 patients operated within 4 days (group 1), and
57 patients operated from 5-Th to 10-Th day after the
clopidogrel discontinuation (group 2). Patients who
underwent reoperation, combined procedures, or off-
pump revascularization were excluded.
Results
There was no mortality in any group. Mean chest tube
losses after the surgical revascularisation were 647.27 ml
in group 1, and 683.67 ml in group 2. The mean quantity
of RBC transfused were 639.36 ml and 470.92 ml retro-
spectively. The mean amount of FFP given to the group 1
was 270 ml, and to group 2 was 197.65 ml. Platelets have
been given to 12 pts in the group 1, and to 1 pt in the
group 2. Crioprecipitate was given to 10 pts and to 3 pts
retrospectively. The median length of stay were 12.8 days
in the group 1, and 18.96 days in the group 2. Detailed
patient characteristics, surgical treatment, complications,
and statistical analysis will be presented.
Conclusions
The urgent and emergent surgical revascularisation
using extracorporeal circulation in patients with acute
coronary syndrome is safe and effective procedure. We
recommend not waiting 5 or more days after the clopi-
dogrel discontinuation. Decision of the timing of CABG
has to be made after careful individual assessment of
the patient clinical status, co-morbidity and angiography.
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